AJP - Endocrinology and Metabolism, Vol 265, Issue 4 E648-E654, Copyright © 1993 by American Physiological Society

ARTICLES

Evidence that intrarenal bradykinin plays a role in regulation of renal function

H. M. Siragy
Department of Internal Medicine, University of Virginia School of Medicine, Charlottesville 22908.

Bradykinin (BK) is produced by the kidney, but the role of the renal kallikrein-kinin system (KKS) in the control of renal function is not understood. We studied the effects of intrarenal infusion of the BK antagonist, D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Phe-Thi-Arg-trifluoroacetic acid (BKA, n = 5) and BK (n = 4) alone or combined with antagonist (BKA 0.025 ng.kg-1 x min-1 + BK 0.25 ng.kg-1 x min-1, n = 4) in uninephrectomized conscious dogs in sodium balance at 10 and 80 meq/day. During low sodium intake, administration of BKA (infusions from 0.025 to 2.5 ng.kg-1 x min-1) caused a significant antidiuresis (P < 0.0001) and antinatriuresis (P < 0.0001) and a decrease in fractional sodium excretion (P < 0.0001). There were no changes in estimated renal plasma flow (RPF) or glomerular filtration rate during intrarenal administration of BKA at 0.025 and 0.25 ng.kg-1 x min-1. A dose of 2.5 ng.kg-1 x min-1 BKA caused a significant decrease in RPF. There were no changes in plasma aldosterone concentration, plasma renin activity, or systemic arterial pressure during intrarenal BKA administration. At 80 meq/day sodium balance (n = 5), intrarenal administration of BKA did not cause any systemic or renal effects. Intrarenal administration of BK at 0.25 ng.kg-1 x min-1 during low sodium balance caused an increase in urine flow rate and urinary sodium excretion. Coinfusion of BK with BKA completely abrogated the renal excretory changes induced by BKA. These data suggest that intrarenal KKS plays a role in control of renal function largely by a tubular mechanism during low sodium intake.

This article has been cited by other articles:

				J. P. Schanstra, J. Duchene, F. Praddaude, P. Bruneval, I. Tack, J. Chevalier, J.-P. Girolami, and J.-L. Bascands Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting Enzyme Systems: Decreased renal NO excretion and reduced glomerular tuft area in mice lacking the bradykinin B2 receptor Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1904 - H1908. [Abstract] [Full Text] [PDF]

				H. M. Siragy, M. de Gasparo, M. El-Kersh, and R. M. Carey Angiotensin-Converting Enzyme Inhibition Potentiates Angiotensin II Type 1 Receptor Effects on Renal Bradykinin and cGMP Hypertension, August 1, 2001; 38(2): 183 - 186. [Abstract] [Full Text] [PDF]

				J. Maly, L. Karasova, M. Simova, S. Vitko, and S. S. El-Dahr Angiotensin II-Induced Hypertension in Bradykinin B2 Receptor Knockout Mice Hypertension, March 1, 2001; 37(3): 967 - 973. [Abstract] [Full Text] [PDF]

				H. M. Siragy, M. de Gasparo, and R. M. Carey Angiotensin Type 2 Receptor Mediates Valsartan-Induced Hypotension in Conscious Rats Hypertension, May 1, 2000; 35(5): 1074 - 1077. [Abstract] [Full Text] [PDF]

				J. Tornel, M. I. Madrid, M. Garcia-Salom, K. J. Wirth, and F. J. Fenoy Role of Kinins in the Control of Renal Papillary Blood Flow, Pressure Natriuresis, and Arterial Pressure Circ. Res., March 17, 2000; 86(5): 589 - 595. [Abstract] [Full Text] [PDF]

				H. MATSUDA, K. HAYASHI, K. ARAKAWA, M. NAITOH, E. KUBOTA, M. HONDA, A. MATSUMOTO, H. SUZUKI, T. YAMAMOTO, F. KAJIYA, et al. Zonal Heterogeneity in Action of Angiotensin-Converting Enzyme Inhibitor on Renal Microcirculation: Role of Intrarenal Bradykinin J. Am. Soc. Nephrol., November 1, 1999; 10(11): 2272 - 2282. [Abstract] [Full Text]

				S.-I. Kitamura, L. A. Carbini, W. H. Simmons, and A. G. Scicli Effects of aminopeptidase P inhibition on kinin-mediated vasodepressor responses Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1664 - H1671. [Abstract] [Full Text] [PDF]

				H. M. Siragy and R. M. Carey Protective Role of the Angiotensin AT2 Receptor in a Renal Wrap Hypertension Model Hypertension, May 1, 1999; 33(5): 1237 - 1242. [Abstract] [Full Text] [PDF]

				A. Bischoff, W. Rascher, and M. C. Michel Bradykinin may be involved in neuropeptide Y-induced diuresis, natriuresis, and calciuresis Am J Physiol Renal Physiol, October 1, 1998; 275(4): F502 - F509. [Abstract] [Full Text] [PDF]

				U. Hilgenfeldt, T. Puschner, U. Riester, J. Finsterle, J. Hilgenfeldt, and E. Ritz Low-salt diet downregulates plasma but not tissue kallikrein-kinin system Am J Physiol Renal Physiol, July 1, 1998; 275(1): F88 - F93. [Abstract] [Full Text] [PDF]

				S. S. El-Dahr, S. Dipp, I. V. Yosipiv, and L. A. Carbini Activation of kininogen expression during distal nephron differentiation Am J Physiol Renal Physiol, July 1, 1998; 275(1): F173 - F182. [Abstract] [Full Text] [PDF]

				H. M. Siragy, A. A. Jaffa, and H. S. Margolius Bradykinin B2 Receptor Modulates Renal Prostaglandin E2 and Nitric Oxide Hypertension, March 1, 1997; 29(3): 757 - 762. [Abstract] [Full Text]

				B. Jover, A. Herizi, and A. Mimran Chronic Kinin Blockade and Effect of Ramipril in Renal Adaptation to Sodium Restriction Hypertension, January 1, 1996; 27(1): 79 - 84. [Abstract] [Full Text]